Skip to content
Clinical Trials – home
Bristol Myers Squibb International Corporation
Sponsor

Bristol Myers Squibb International Corporation

Belgium Terhulpsesteenweg 185, 1170 Watermael-Boitsfort, Belgium

About the sponsor

Research activity includes non-small cell lung cancer across operable, locally advanced, metastatic, and stage IV settings, as well as small cell lung cancer in extensive-stage disease. The portfolio also extends to early-stage and resected lung cancer, with attention to immunotherapy and combination treatment approaches.

  • Non-small cell lung cancer
  • Small cell lung cancer
  • Early-stage and resected lung cancer
  • Metastatic thoracic malignancies

These studies reflect sustained interest in lung cancer control across both curative-intent and advanced disease settings.

About Specializations

Bristol Myers Squibb International Corporation runs clinical trials in conditions such as Hepatocellular carcinoma, Non-small cell lung cancer, Neoplasm, Gastric cancer, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

26 clinical trials

Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol Myers Squibb International Corporation
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Bristol Myers Squibb International Corporation
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ipilimumab
  • Sponsor:Bristol Myers Squibb International Corporation
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Daratumumab
  • Sponsor:Bristol Myers Squibb International Corporation
Countries:AustriaAustria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:Bristol Myers Squibb International Corporation
Countries:AustriaAustria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:Bristol Myers Squibb International Corporation
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Bristol Myers Squibb International Corporation

Gastrooesophageal cancer+5

Not recruiting
Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:Bristol Myers Squibb International Corporation
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ipilimumab
  • Sponsor:Bristol Myers Squibb International Corporation

Neoplasm

Not recruiting
Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Ipilimumab
  • Sponsor:Bristol Myers Squibb International Corporation
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Paclitaxel
  • Sponsor:Bristol Myers Squibb International Corporation
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Farletuzumab Ecteribulin
  • Sponsor:Bristol Myers Squibb International Corporation

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.